Hyperbaric Oxygen Adjunct

SOC → SCF-DBI Logic Translation

Purpose

Hyperbaric Oxygen Therapy (HBOT) is an adjunctive treatment involving administration of 100% oxygen under increased atmospheric pressure to augment tissue oxygen delivery, improve host defense mechanisms, support ischemic tissue recovery, and enhance wound healing.

HBOT is not a definitive intervention for the underlying pathology. Rather, it serves as a biologic amplifier that augments recovery following source control, debridement, revascularization, reconstruction, and standard medical therapy.

Under SCF-DBI, Hyperbaric Oxygen Adjunct therapy is not merely oxygen supplementation.

It is restoration of the Oxygen–Metabolic Recovery Network (OMRN) through optimization of oxygen bioavailability, mitochondrial function, immune competence, and regenerative signaling.

SOC Definition

Clinical Objective

Utilize hyperbaric oxygen to:

• Enhance tissue oxygenation
• Improve leukocyte bactericidal activity
• Reduce tissue edema
• Support ischemic tissue salvage
• Facilitate wound healing
• Improve graft and flap survival
• Enhance recovery following definitive interventions
• Reduce long-term tissue dysfunction

Applicable Conditions

Selected Ischemic Wounds

Examples:

• Compromised skin grafts
• Threatened flaps
• Crush injuries
• Acute traumatic ischemia
• Reperfusion injury
• Radiation-induced tissue injury

Necrotizing Infections

Examples:

• Necrotizing fasciitis (after surgical source control)
• Fournier gangrene
• Clostridial myonecrosis
• Gas gangrene

Chronic Refractory Wounds

Examples:

• Diabetic foot ulcers
• Chronic osteomyelitis
• Non-healing ischemic ulcers
• Radiation-associated wounds

Decompression and Gas Disorders

Examples:

• Decompression sickness
• Arterial gas embolism
• Selected carbon monoxide poisoning scenarios

SCF-DBI Translation

Core Concept

SOC views HBOT as:

Adjunctive delivery of hyperbaric oxygen to enhance tissue oxygen availability.

SCF-DBI views HBOT as:

Restoration of the Oxygen–Metabolic Recovery Network through coordinated enhancement of oxygen transport, mitochondrial efficiency, immune competence, and regenerative adaptation.

The objective extends beyond oxygen delivery.

The objective is preservation and restoration of:

1. Oxygen bioavailability
2. Mitochondrial function
3. Immune efficiency
4. Microvascular competence
5. Regenerative signaling
6. Functional tissue resilience

SCF-DBI Oxygen–Metabolic Failure Architecture

Domain 1

Oxygen–Metabolic Recovery Failure

SOC Focus

Increase dissolved oxygen availability.

SCF-DBI Focus

Reverse integrated oxygen–metabolic dysfunction.

Failure Cascade

Tissue injury

↓

Hypoxia

↓

Mitochondrial dysfunction

↓

ATP depletion

↓

Immune inefficiency

↓

Microvascular compromise

↓

Impaired regeneration

↓

Delayed healing

↓

Functional decline

SCF Classification

Oxygen–Metabolic Recovery Failure Syndrome (OMRFS)

A state in which inadequate tissue oxygen utilization disrupts coordinated metabolic and regenerative recovery.

Output

Oxygen–Metabolic Severity Score (OMSS)

Domain 2

Oxygen–Metabolic Recovery Index

Major SCF-DBI Enhancement

Selected Enhancement:

Oxygen–Metabolic Recovery Index (OMRI)

This becomes the principal SCF-DBI enhancement for Hyperbaric Oxygen Adjunct therapy.

Rationale

SOC evaluates:

• Completion of HBOT sessions
• Clinical wound progression
• Symptom improvement
• Infection response

SCF-DBI evaluates:

Whether hyperbaric oxygen is restoring effective oxygen utilization and cellular energy recovery.

The central question becomes:

Is oxygen delivery translating into meaningful metabolic rescue and regenerative advancement?

Failure Cascade

Persistent hypoxia

↓

Mitochondrial inefficiency

↓

Reduced ATP generation

↓

Impaired leukocyte function

↓

Delayed angiogenesis

↓

Tissue deterioration

↓

Functional compromise

Recovery Cascade

HBOT administration

↓

Enhanced plasma oxygenation

↓

Improved mitochondrial respiration

↓

ATP restoration

↓

Immune potentiation

↓

Angiogenic stimulation

↓

Regenerative progression

↓

Functional recovery

Assessment Domains

Recovery States

Output

Oxygen–Metabolic Recovery Index (OMRI)

Domain 3

Mitochondrial Resilience Intelligence

SCF-DBI Enhancement

Cellular energy restoration determines tissue adaptability.

Assessment Domains

Output

Mitochondrial Resilience Score (MRS-HBO)

Domain 4

Immuno-Oxygen Surveillance

SCF-DBI Enhancement

Hyperoxia influences host defense capacity.

Assessment Domains

Output

Immuno-Oxygen Score (IOS)

Domain 5

Microvascular Regenerative Intelligence

SCF-DBI Enhancement

Oxygen facilitates angiogenesis and tissue restoration.

Assessment Domains

Recovery States

Output

Microvascular Regenerative Score (MRS-R)

Domain 6

Functional Recovery Readiness

SCF-DBI Enhancement

Adjunctive therapies should improve meaningful outcomes.

Assessment Domains

Readiness States

Output

Functional Recovery Score (FRS-HBO)

Domain 7

RHENOVA Oxygen–Metabolic Matrix

SCF-DBI Enhancement

The objective is amplification of host recovery after definitive therapy.

Recovery Domains

Metabolic Recovery

Biologic Recovery

Functional Recovery

Output

RHENOVA Oxygen–Metabolic Recovery Score (ROMRS)

RHENOVA Integration

R1 — Survival Preservation

Prevent:

• Progressive tissue hypoxia
• Infectious deterioration
• Ischemic tissue loss

Output:

Oxygen Rescue Status

R2 — Recovery Optimization

Restore:

• Oxygen utilization efficiency
• Mitochondrial competence
• Immune effectiveness

Output:

Recovery Readiness Score

R3 — Regenerative Preservation

Protect:

• Microvascular architecture
• Cellular energy systems
• Regenerative signaling pathways

Output:

Metabolic Preservation Profile

R4 — Functional Restoration

Achieve:

• Enhanced wound recovery
• Improved tissue resilience
• Accelerated rehabilitation

Output:

Oxygen Restoration Matrix

R5 — Long-Term Resilience

Prevent:

• Chronic hypoxic dysfunction
• Delayed healing
• Recurrent infection
• Persistent disability
• Regenerative exhaustion

Output:

Oxygen–Metabolic Resilience Profile

SCF-DBI Hyperbaric Oxygen Adjunct Workflow

Step 1

Identify Oxygen–Metabolic Recovery Failure.

Output

Oxygen–Metabolic Severity Score.

Step 2

Initiate adjunctive hyperbaric oxygen therapy following definitive SOC interventions.

Output

Oxygen–Metabolic Recovery Network Restoration Confirmation.

Step 3

Activate the Oxygen–Metabolic Recovery Index.

Output

Oxygen–Metabolic Recovery Index.

Step 4

Assess mitochondrial resilience.

Output

Mitochondrial Resilience Score.

Step 5

Evaluate immuno-oxygen adaptation.

Output

Immuno-Oxygen Score.

Step 6

Assess microvascular regenerative progression.

Output

Microvascular Regenerative Score.

Step 7

Determine functional recovery readiness.

Output

Functional Recovery Score.

Step 8

Generate the RHENOVA Oxygen–Metabolic Matrix.

Output

RHENOVA Oxygen–Metabolic Recovery Score.

Glossary

SCF Principle Alignment

INDEX

SCF-ADJUNCT-HYPERBARIC-OXYGEN-0001

SCF-DBI-OXYGEN-METABOLIC-RECOVERY-NETWORK-0001

SCF-DBI-OXYGEN-METABOLIC-RECOVERY-FAILURE-SYNDROME-0001

SCF-DBI-OXYGEN-METABOLIC-RECOVERY-INDEX-0001

SCF-DBI-OXYGEN-METABOLIC-SEVERITY-SCORE-0001

SCF-DBI-MITOCHONDRIAL-RESILIENCE-SCORE-HBO-0001

SCF-DBI-IMMUNO-OXYGEN-SCORE-0001

SCF-DBI-MICROVASCULAR-REGENERATIVE-SCORE-0001

SCF-DBI-FUNCTIONAL-RECOVERY-SCORE-HBO-0001

SCF-DBI-RHENOVA-OXYGEN-METABOLIC-MATRIX-0001

SCF-HYPERBARIC-OXYGEN-ADJUNCT-WORKFLOW-0081

SCF-HYPERBARIC-OXYGEN-ADJUNCT-MASTER-0001